Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News ONCOTHYREON Inc ONTY

Healthcare Biotechnology
"Oncothyreon Inc is a clinical-stage biopharmaceutical company. It develops and commercializes synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients."
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ONTY)

Oncothyreon Announces Corporate Name Change to Cascadian Therapeutics (NASDAQ: CASC)

GlobeNewswire June 8, 2016

Oncothyreon Presents Phase 1b Results of ONT-380 in Combination with T-DM1 in HER2+ Metastatic Breast Cancer at ASCO

GlobeNewswire June 5, 2016

FibroGen Reports Financial Results for the First Quarter of 2016

GlobeNewswire May 9, 2016

Oncothyreon Reports First Quarter 2016 Financial Results & Provides Corporate Update

GlobeNewswire May 9, 2016

4 Biotech Stocks to Buy at Beaten Down Prices

Accesswire April 27, 2016

Oncothyreon Highlights Novel Checkpoint Kinase 1 Inhibitors at American Association for Cancer Research (AACR) Annual Meeting 2016

GlobeNewswire April 19, 2016

Oncothyreon Appoints Scott D. Myers Chief Executive Officer

GlobeNewswire March 29, 2016

Stocks To Buy: These Are Being Considered on Monday 3/21/2016

Accesswire March 21, 2016

Three Stocks To Watch Friday Afternoon 3/18/2016

Accesswire March 18, 2016
View More News ››

Opinion & Analysis (NDAQ:ONTY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ONTY)

Finally

It took 4 and a half years to do it, but I finally broke even.  Anyone else out there from the Biomira days still following this?AB
AngryBob - July 21, 2011

Nice timing..

 the managemnet of this co should be shot....idiots. I hope they enjoy spending that cash. oh well it gives us long term suckers...
Traderdan$$$ - September 24, 2010

Finally

 A news realease that means something.
Traderdan$$$ - June 18, 2010

WHO FRIGGIN CARES!

The company is broke in 12 months! HOW ABOUT A POSITIVE NEWS REALEASE ON A DRUG !!!! Maybe Stimuvax trials restarted or anything to get...
Traderdan$$$ - June 3, 2010

Very quiet...

that's for sure and for a very very long time. Maybe todays announcement by Merck will get things rolling again and we'll see a...
Traderdan$$$ - December 10, 2009

RE: SAD

Not much happening on this board lol. We are up 18% today. I have a tiny position so i almost forgot about it. Have a nice day :-)
maoae - December 10, 2009
View more Bullboard ››

Alphamin Resources Corp.

Alphamin Resources Corp.

Alphamin Resources Corp. is a Mauritius-based company, which is engaged in the production and sale of tin concentrate from ...
View More »